Cogentis Therapeutics

Cogentis is committed to finding cures for a number of neurodegenerative diseases. Our groundbreaking research will lead to treatments for Alzheimer’s disease, fronto-temporal dementia, progressive supranuclear palsy and more.

Website :

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now closed for Finnish, Italian, South Korean, Taiwanese, and U.S. companies. The call will open soon for South African companies.

Country Programs



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links